373 related articles for article (PubMed ID: 34884393)
1. Female Oncofertility: Current Understandings, Therapeutic Approaches, Controversies, and Future Perspectives.
Vo KCT; Kawamura K
J Clin Med; 2021 Dec; 10(23):. PubMed ID: 34884393
[TBL] [Abstract][Full Text] [Related]
2. Ovarian damage from chemotherapy and current approaches to its protection.
Spears N; Lopes F; Stefansdottir A; Rossi V; De Felici M; Anderson RA; Klinger FG
Hum Reprod Update; 2019 Nov; 25(6):673-693. PubMed ID: 31600388
[TBL] [Abstract][Full Text] [Related]
3. Advances in the Treatment and Prevention of Chemotherapy-Induced Ovarian Toxicity.
Cho HW; Lee S; Min KJ; Hong JH; Song JY; Lee JK; Lee NW; Kim T
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33096794
[TBL] [Abstract][Full Text] [Related]
4. Do cancer therapies damage the uterus and compromise fertility?
Griffiths MJ; Winship AL; Hutt KJ
Hum Reprod Update; 2020 Feb; 26(2):161-173. PubMed ID: 31863097
[TBL] [Abstract][Full Text] [Related]
5. Can Some Anticancer Treatments Preserve the Ovarian Reserve?
Vallet N; Boissel N; Elefant E; Chevillon F; Pasquer H; Calvo C; Dhedin N; Poirot C
Oncologist; 2021 Jun; 26(6):492-503. PubMed ID: 33458904
[TBL] [Abstract][Full Text] [Related]
6. Modeling of live-birth rates and cost-effectiveness of oocyte cryopreservation for cancer patients prior to high- and low-risk gonadotoxic chemotherapy.
Lyttle Schumacher B; Grover N; Mesen T; Steiner A; Mersereau J
Hum Reprod; 2017 Oct; 32(10):2049-2055. PubMed ID: 28938728
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Chemotherapy on the Ovaries: Molecular Aspects and the Prevention of Ovarian Damage.
Sonigo C; Beau I; Binart N; Grynberg M
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717833
[TBL] [Abstract][Full Text] [Related]
8. Impact of first-line cancer treatment on the follicle quality in cryopreserved ovarian samples from girls and young women.
Pampanini V; Wagner M; Asadi-Azarbaijani B; Oskam IC; Sheikhi M; Sjödin MOD; Lindberg J; Hovatta O; Sahlin L; Björvang RD; Otala M; Damdimopoulou P; Jahnukainen K
Hum Reprod; 2019 Sep; 34(9):1674-1685. PubMed ID: 31411325
[TBL] [Abstract][Full Text] [Related]
9. Combining fertility preservation procedures to spread the eggs across different baskets: a feasibility study.
Delattre S; Segers I; Van Moer E; Drakopoulos P; Mateizel I; Enghels L; Tournaye H; De Vos M
Hum Reprod; 2020 Nov; 35(11):2524-2536. PubMed ID: 32951035
[TBL] [Abstract][Full Text] [Related]
10. Preservation of fertility and ovarian function and minimizing chemotherapy-induced gonadotoxicity in young women.
Blumenfeld Z; Avivi I; Ritter M; Rowe JM
J Soc Gynecol Investig; 1999; 6(5):229-39. PubMed ID: 10554760
[TBL] [Abstract][Full Text] [Related]
11. Molecular Mechanism and Prevention Strategy of Chemotherapy- and Radiotherapy-Induced Ovarian Damage.
Kim S; Kim SW; Han SJ; Lee S; Park HT; Song JY; Kim T
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299104
[TBL] [Abstract][Full Text] [Related]
12. The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservation.
Winship AL; Griffiths M; Lliberos Requesens C; Sarma U; Phillips KA; Hutt KJ
Hum Reprod; 2020 Aug; 35(8):1864-1874. PubMed ID: 32604417
[TBL] [Abstract][Full Text] [Related]
13. Consequences of chemotherapeutic agents on primordial follicles and future clinical applications.
Kim SY; Cho GJ; Davis JS
Obstet Gynecol Sci; 2019 Nov; 62(6):382-390. PubMed ID: 31777733
[TBL] [Abstract][Full Text] [Related]
14. Successful fertility preservation following ovarian tissue vitrification in patients with primary ovarian insufficiency.
Suzuki N; Yoshioka N; Takae S; Sugishita Y; Tamura M; Hashimoto S; Morimoto Y; Kawamura K
Hum Reprod; 2015 Mar; 30(3):608-15. PubMed ID: 25567618
[TBL] [Abstract][Full Text] [Related]
15. Beyond fertility preservation: role of the oncofertility unit in the reproductive and gynecological follow-up of young cancer patients.
Massarotti C; Scaruffi P; Lambertini M; Sozzi F; Remorgida V; Anserini P
Hum Reprod; 2019 Aug; 34(8):1462-1469. PubMed ID: 31339999
[TBL] [Abstract][Full Text] [Related]
16. Update on fertility preservation from the Barcelona International Society for Fertility Preservation-ESHRE-ASRM 2015 expert meeting: indications, results and future perspectives.
Martinez F
Hum Reprod; 2017 Sep; 32(9):1802-1811. PubMed ID: 29117320
[TBL] [Abstract][Full Text] [Related]
17. Response to ovarian stimulation in patients facing gonadotoxic therapy.
Johnson LN; Dillon KE; Sammel MD; Efymow BL; Mainigi MA; Dokras A; Gracia CR
Reprod Biomed Online; 2013 Apr; 26(4):337-44. PubMed ID: 23415997
[TBL] [Abstract][Full Text] [Related]
18. Safety and usefulness of cryopreservation of ovarian tissue to preserve fertility: a 12-year retrospective analysis.
Imbert R; Moffa F; Tsepelidis S; Simon P; Delbaere A; Devreker F; Dechene J; Ferster A; Veys I; Fastrez M; Englert Y; Demeestere I
Hum Reprod; 2014 Sep; 29(9):1931-40. PubMed ID: 24958067
[TBL] [Abstract][Full Text] [Related]
19. Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
Abir R; Ben-Aharon I; Garor R; Yaniv I; Ash S; Stemmer SM; Ben-Haroush A; Freud E; Kravarusic D; Sapir O; Fisch B
Hum Reprod; 2016 Apr; 31(4):750-62. PubMed ID: 26848188
[TBL] [Abstract][Full Text] [Related]
20. Unraveling the mechanisms of chemotherapy-induced damage to human primordial follicle reserve: road to developing therapeutics for fertility preservation and reversing ovarian aging.
Szymanska KJ; Tan X; Oktay K
Mol Hum Reprod; 2020 Aug; 26(8):553-566. PubMed ID: 32514568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]